Gema Ibarra/Dreamstime
Vaccine Vials Id 176712152 © Gema Ibarra Dreamstime

Corning Wins Funding to Ramp Up Vaccine Vial Production

June 9, 2020
Pharmaceutical companies warned that vaccine production might hit a bottleneck if enough vials weren’t available.

Corning Inc. announced June 9 that it was accepting $204 million from the U.S. Department of Health and Human Services to ramp up domestic production of glass vaccine vials. According to Reuters, AstraZeneca and Johnson & Johnson, both of which have COVID-19 vaccines in development, have raised concerns about the available supply of the vials.

The funding was provided by the Biomedical Advanced Research and Development Authority, or BARDA, which is also helping fund COVID-19 vaccines and treatments at several United States companies. In a statement, Corning said that “designated” fellow BARDA partners would get priority access to the vial supply. Pfizer signed a long term agreement to purchase vials in May, according to Reuters.

Corning’s CEO, Wendell P. Weeks, said Corning was “delighted” to be selected by BARDA. “Corning is ready to do our part in the fight against the pandemic, as well as to help prepare for future public health emergencies.”

The vials will use Corning’s Valor glass, the result of a collaboration between Corning, Merck and Pfizer. According to Corning, the vials allow for faster filling and capping than conventional vials, reportedly increasing the manufacturing throughput by up to 50% on conventional filling lines. The money will be used to scale up manufacturing assets for the vials in three U.S. locations: Big Flats, New York; Durham, North Carolina; and Vineland, New Jersey.

Although the glass vials are used in lots of pharmaceutical products requiring sterile containment, billions of vials will be needed soon depending on how quickly Johnson & Johnson, Pfizer, AstraZeneca, and others manage to develop a viable vaccine for the novel coronavirus. Pharmaceutical companies have been working at an unprecedented pace to develop a vaccine and deploy it in roughly a year since the virus’ genetic sequence was made available in January. Such a deployment would be unprecedented in the history of epidemiology but would likely rely on emergency use authorizations.

Popular Sponsored Recommendations

Gain a competitive edge with real-world lessons on private 5G networks

Nov. 16, 2023
The use of private networks in manufacturing applications is rapidly growing. In this paper, we present valuable insights and lessons learned from the field with the goal of enhancing...

Future-Proofing Your Business with Smart Manufacturing

Jan. 2, 2024
An IndustryWeek-Plant Services-Smart Industry-Automation World-hosted webinar sponsored by Amazon Web Services

Top 3 Ways AI is Transforming Manufacturing Operations

Feb. 17, 2024
Unlock the power of Industry 4.0 with AI and IoT. Explore how real-time data and automation are reshaping manufacturing, driving efficiency and quality to new heights. Dive into...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!